Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhuolin Granules
- Development stage
- Preclinical
- Lead developer
- Changzhou Hospital of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
**Zhuolin Granules** is an orally administered traditional Chinese herbal formula investigated by Changzhou Affiliated Hospital of Nanjing University of Chinese Medicine for recurrent urinary tract infection in postmenopausal women. The registered ChiCTR study evaluates the formula in relation to changes in host microecology, including intestinal microbial composition. Its individual botanical constituents, standardized active ingredients, and molecular targets were not identified in the available public trial record; therefore, a specific pharmacologic mechanism cannot be assigned.
- Other names
- Zhuolin Decoction濯淋颗粒
Beyond the preview
Go deeper on Zhuolin Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhuolin Granules.